104 results on '"Illum L"'
Search Results
2. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: In vivo studies
3. CriticalSorb™ Promotes Permeation of Flux Markers Across Isolated Rat Intestinal Mucosae and Caco-2 Monolayers
4. Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device
5. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: In vitro characterisation studies
6. The Effect of Blood Sampling Site and Physicochemical Characteristics of Drugs on Bioavailability After Nasal Administration in the Sheep Model
7. Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
8. Development of Systems for Targeting the Regional Lymph Nodes for Diagnostic Imaging: In Vivo Behaviour of Colloidal PEG-Coated Magnetite Nanospheres in the Rat Following Interstitial Administration
9. Application of Novel Biomaterials in Colloidal Drug Delivery Systems
10. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology
11. Activation of the Mononuclear Phagocyte System by Poloxamine 908: Its Implications for Targeted Drug Delivery
12. Nanospheres prepared from poly(β-malic acid) benzyl ester copolymers: evidence for their in vitro degradation
13. Nasal administration of an angiotensin antagonist in the rat model: Effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems
14. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms
15. The effect of the nasal cycle on mucociliary clearance
16. Characterisation of poly(lactic acid):poly(ethyleneoxide) (PLA:PEG) nanoparticles using the self-consistent theory modelling approach
17. Nasal delivery of chitosan–DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice
18. Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation
19. Self-consistent field modelling of poly(lactic acid)–poly(ethylene glycol) particles
20. Preparation of ultrafine silica- and PEG-coated magnetite particles
21. Chitosan as a novel nasal delivery system for vaccines
22. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation
23. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers
24. Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles
25. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
26. Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.
27. Polylactide-poly(ethylene Glycol) Micellar-like Particles as Potential Drug Carriers: Production, Colloidal Properties and Biological Performance.
28. Transport of Nanoparticles Across the Rat Nasal Mucosa.
29. Gastrointestinal transit of dosage forms in the pig.
30. Schizophrenia and Drug Delivery Systems.
31. Sustained release chitosan microspheres prepared by novel spray drying methods.
32. The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.
33. NASAL ADMINISTRATION OF MORPHINE-6-GLUCURONIDE IN SHEEP-A PHARMACOKINETIC STUDY.
34. Preparation of Human Serum Albumin Microspheres by a Novel Acetone-Heat Denaturation Method.
35. Egg albumin microspheres containing paracetamol for oral administration. II. In vivo investigation.
36. Egg albumin microspheres containing paracetamol for oral administration. I. In vitro characterization.
37. Novel graft copolymers for in vivo targeting of colloidal carriers.
38. Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide).
39. Human Serum Albumin as a Probe for Surface Conditioning-A Study of the Ageing Effect.
40. Preparation of Sub-100 nm Human Serum Albumin Nanospheres Using a pH-Coacervation Method.
41. OR03-6 Intranasal administration of Human Growth Hormone (CP024) and induction of IGF-1 in healthy volunteers.
42. 16. A dual radionuclide study to assess the effect of the nasal cycle on nasal drug delivery.
43. Cyclodextrins as protection agents against enhancer damage in nasal delivery systems I. Assessment of effect by measurement of erythrocyte haemolysis
44. Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane
45. Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep
46. Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models
47. The colloidal properties of surfactant-free biodegradable nanospheres from poly(β-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide)
48. Adsorption behaviour and conformation of selected poly(ethylene oxide) copolymers on the surface of a model colloidal drug carrier
49. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen
50. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.